Sarraf Pasha 4
4 · Cue Biopharma, Inc. · Filed Mar 12, 2025
Insider Transaction Report
Form 4
Sarraf Pasha
Director
Transactions
- Award
Stock Option (right to buy)
2025-03-10+48,800→ 48,800 totalExercise: $1.03Exp: 2035-03-09→ Common Stock (48,800 underlying)
Footnotes (2)
- [F1]Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
- [F2]This option was granted on March 10, 2025. The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments.